Journals / European Journal of Forensic Sciences / 2016 / Cilt: 3 - Sayı: 2

Fentanyl-related cases. Th Greece e situation in Greece

Pages
16–20
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Warning and information to users and practitioners about the possibility of adverse effects, even death, law enforcement action, prescribing regulations, and availability of rapid and accurate analytical methods for the determination of fentanyl in biological specimens, must be under deliberation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Fentanyl is used as a pre-anesthetic medication, and it is also prescribed for the management of chronic pain through the delivery method of transdermal patches.
📊
Key Findings & Data:As a result, a significant number of fentanyl-related deaths have been recorded in many countries, as well as in Greece.
💡
Conclusion & Impact:Warning and information to users and practitioners about the possibility of adverse effects, even death, law enforcement action, prescribing regulations, and availability of rapid and accurate analytical methods for the determination of fentanyl in biological specimens, must be under deliberation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Fentanyl is used as a pre-anesthetic medication, and it is also prescribed for the management of chronic pain through the delivery method of transdermal patches. It is used or abused, as a recreational drug, worldwide. As a result, a significant number of fentanyl-related deaths have been recorded in many countries, as well as in Greece. The aim of this study is to present the current situation in Greece through the report of specific fentanyl-related cases and to discuss the different aspects of fentanyl abuse. Methods: A gas chromatography-mass spectrometric method was developed, validated and applied for the determination of fentanyl in biological fluids during the investigation of fentanyl-related cases. Results: Eight cases, lethal or not, have been recorded the last 4 years in Greece, where fentanyl blood concentration was found up to 22.7 ng mL. Five of the cases concerned the therapeutic use of fentanyl, and three were related to abuse of the drug. Furthermore, six of these cases concerned fentanyl transdermal patches. Conclusions: The commercial success of transdermal fentanyl is impressive and ensures that the drug will remain in the market for years to come. The litigation surrounding the use and abuse of fentanyl patches is a major concern today. Warning and information to users and practitioners about the possibility of adverse effects, even death, law enforcement action, prescribing regulations, and availability of rapid and accurate analytical methods for the determination of fentanyl in biological specimens, must be under deliberation.

🔖

Cite This Article

PAPOUTSİS, I., NİKOLAOU, P., ATHANASELİS, S., VARDAKOU, I., SPİLİOPOULOU, C., STEFANİDOU, M. (2022). Fentanyl-related cases. Th Greece e situation in Greece. European Journal of Forensic Sciences, Cilt: 3 - Sayı: 2, 16–20. https://ajindex.com/articles/510903

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Krinsky CS, Lathrop SL, Crossey M, Baker G, Zumwalt R. A toxicologybased review of fentanyl-related deaths in New Mexico (1986-2007). Am J Forensic Med Pathol 2011;32:347-51.
  2. Yaksh TL, Wallace MS. Opioids, analgesia, and pain management. In: Brunton LL, Chabner BA, Knollman BC, editors. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill Medical; 2011. p. 481-526. Available from: http://www.emcdda.europa.eu/publications/drugprofiles/fentanyl. [Last accessed on 2015 Jul 02]. Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. 7th ed. Foster City, California: Biomedical Publications; 2004.
  3. D'Orazio JL, Fischel JA. Recurrent respiratory depression associated with fentanyl transdermal patch gel reservoir ingestion. J Emerg Med 2012;42:543-8.
  4. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000;283:1710-4. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Fentanyl in Europe EMCDDA trends potter study. Report from an EMCDDA Expert Meeting 9 to 10 October; 2012. Jumbelic MI. Deaths with transdermal fentanyl patches. Am J Forensic Med Pathol 2010;31:18-21. Available from: http://www.paihdelinkki.fi/en/info-bank/articles/drugs- medicinal-substances-and-other-intoxicants/fentanyl. [Last accessed on 2015 Jul 02]. Centers for Disease Control and Prevention (CDC). Non-pharmaceutical fentanyl-related deaths: Multiple states, April 2005- March 2007. MMWR Morb Mortal Wkly Rep 2008;57:793-6. EMCDDA-Europol 2011 Annual Report on the Implementation of Council Decision 2005/387/JHA. Lane ME. The transdermal delivery of fentanyl. Eur J Pharm Biopharm 2013;84:449-55. Available from: http://www.emcdda.europa.eu/events/2012/annual- report. [Last accessed on 2015 Jul 02]. Denton JS, Donoghue ER, McReynolds J, Kalelkar MB. An epidemic of illicit fentanyl deaths in Cook County, Illinois: September 2005 through April 2007. J Forensic Sci 2008;53:452-4. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm300747. htm. [Last accessed on 2015 Jul 02]. Drug Enforcement Administration (DEA), U.S. Department of Justice. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Interim rule with request for comments. Fed Regist 2007;72:20039-47. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual Report 2008. The State of Drugs Problem in Europe. Flannagan LM, Butts JD, Anderson WH. Fentanyl patches left on dea